Our diagnostics approach, team, career opportunities and investors

OUR MISSION

At Inflammatix, we are reimagining diagnostics

Inflammatix will create and commercialize best-in-class host-response diagnostics to resolve major clinical and public health challenges.

Better patient care is at the core of what we do. We achieve better patient care through our innovative approach to developing diagnostics–our tests read the patient’s immune system to help us understand the cause of infection and the degree of its severity. Armed with this knowledge, the clinician can treat the patient appropriately and within minutes.

Precision medicine on demand

There is a critical unmet need for quickly and accurately characterizing infections in patients who are acutely ill. Our expert bioinformatics and assay development teams are building a host response-based diagnostics pipeline that includes tests for acute infection and sepsis, emerging infectious diseases, autoimmune diseases, tropical infections, transplant rejection and other conditions.

We are initially focused on developing tests for acute bacterial infections, viral infections, and sepsis based on patent-pending biomarkers exclusively licensed from Stanford University.

Leadership

Tim Sweeney, MD, PhDCo-Founder and CEO

Jonathan RomanowskyCo-Founder and Chief Business Officer

Oliver Liesenfeld, MDChief Medical Officer

Joao Fonseca, PhDChief Technology Officer

Amy BoyleChief Operating Officer

Ljubomir Buturovic, PhDVice President of Machine Learning

Yudong He, PhD, MBAVice President of Computational Biology

Nina Menezes, PhDVice President of Marketing

Pamela Lambert, MS, PMP, CLSVice President of Program Management & Design Assurance

Paul Fleming, PhDVice President of Engineering

Howard SoloveiVice President Finance and Business Operations

Diana LaneVice President Quality Assurance and Regulatory Affairs

Purvesh Khatri, PhDCo-Founder and Scientific Advisor

Board of Directors

Tim Sweeney, MD, PhDCo-Founder and CEO

Steve TablakFormer Chairman and CEO, GeneWeave

Michael Rubin, MD, PhDFounder and CEO at Northpond Ventures

Ken Bahk, PhDCEO of Lakewood Holdings

Justin KaoPartner at Khosla Ventures

Advisors

Jesús Bermejo-Martin, MD, PhDPrincipal Investigator, BioSepsis

Hector Wong, MDProfessor of Pediatrics

Nathan A LedeboerProfessor and Vice Chair of Pathology

Jim DucharmeClinical Professor of Medicine

Investors

Inflammatix investors include the following groups:

Partner with Us!

Inflammatix is establishing partnerships with diagnostic instrument, companion therapeutic and commercial distribution companies across the globe. Contact us at info@inflammatix.com to explore collaboration opportunities.

Our current partners include Genentech, DRIVe, BARDA and DARPA